Lee Limbird

Last updated
Lee E. Limbird
Born
Lee Eberhardt

(1948-11-27) November 27, 1948 (age 75)
Philadelphia, Pennsylvania
Alma mater College of Wooster, University of North Carolina, Chapel Hill
Awards John J. Abel Award, Julius Axelrod Award
Scientific career
Fields Pharmacology
Institutions Vanderbilt University, Meharry Medical College, Fisk University

Lee Limbird (born November 27, 1948, in Philadelphia, Pennsylvania) is a pharmacologist, Dean of the School of Natural Science, Mathematics and Business & Professor in the Department of Life and Physical Sciences at Fisk University, Nashville, Tennessee. [1] [2]

Contents

Limbird has been recognized for "outstanding scientific contributions in research and mentoring in pharmacology", in particular her "pioneering research on alpha-2 adrenergic receptors and how they relate to the regulation of blood pressure, sedation, pain suppression and opioid drug action". Among other awards, she received the Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET) in 2013. [2]

Early life and education

Lee Eberhardt was born on November 27, 1948, in Philadelphia, Pennsylvania. [3]

Eberhardt attended the College of Wooster in Wooster, Ohio, working in her fourth year with analytical chemist Theodore Roosevelt Williams. Her independent study project, “Role of CPK Isoenzymes in the Diagnosis of Myocardial Infarction,” was co-mentored by Galen Wagner at Duke University. [4] Eberhardt received her B.A. in chemistry in 1970 from the College of Wooster. [5] [6] She subsequently married Tom Limbird, who was a student and resident in orthopedic surgery at Duke. [4]

In 1970, Lee Limbird joined the PhD program in biochemistry at the University of North Carolina, Chapel Hill. She left after two semesters but was encouraged to continue working on creatine phosphokinase (CPK) isoenzyme detection as a research assistant with Charles Roe at Duke University. Limbird's research, showing the importance of the MB isozyme of CPK in myocardial tissue for diagnosis of cardiac infarction, was accepted as the basis for her PhD degree, awarded in 1973 by UNC Chapel Hill. She then became a postdoctoral student, working with Robert J. Lefkowitz on the molecular basis of cardiac disease. [4] One of his first students, she is credited with helping to establish the research direction of the Lefkowitz laboratory. [7]

Career

In 1979, Limbird joined Vanderbilt University as an Assistant Professor of Pharmacology. She led her own lab for several years, focusing on the actions of epinephrine and norepinephrine in alpha2-adrenergic receptor pathways. [4] [5]

Limbird served as Chair of the Department of Pharmacology at the Vanderbilt School of Medicine from 1991-1998, and was the first Associate Vice Chancellor for Research of the Vanderbilt University Medical Center from 1998-2003. [4] [5] With Hal Moses, Limbird was instrumental in determining the 1997 strategic plan for the program. [8]

After 25 years at Vanderbilt, Limbird chose to join minority-serving institutions, in hopes of using her scientific administrative, and personal experience to help counter the impact of systemic racism. [4] In 2005, she became Vice President for Research and Chair of the Department of Biomedical Sciences at Meharry Medical College. In 2008, Limbird became Dean of the School of Natural Sciences, Mathematics and Business Administration at Fisk University in Nashville, Tennessee. [5]

Research

Much of Limbird's research has explored the activity of G-protein coupled receptors. She has demonstrated how alpha-2 adrenergic receptors are involved in regulation of blood pressure, suppression of pain, sedation and the action of opioid drugs. She has developed techniques for selectively manipulating such receptors. [2]

Limbird is the author of Cell Surface Receptors: A Short Course in Theory and Methods (1985, 1996, 2004); co-editor with Joel Hardman of the 9th (1995) and 10th (2001) editions of Goodman and Gilman’s Pharmacological Basis of Therapeutics ; [5] editor of Alpha2-Adrenergic Receptors (1988) and co-editor with Stephen Lanier of α2-Adrenergic Receptors. Structure, Function and Therapeutic Implications (1996). [3] Limbird has served on the editorial boards of the Journal of Biological Chemistry , the American Journal of Physiology , and Molecular Pharmacology . [5] [3]

Awards

Related Research Articles

<span class="mw-page-title-main">Alfred G. Gilman</span> American pharmacologist

Alfred Goodman Gilman was an American pharmacologist and biochemist. He and Martin Rodbell shared the 1994 Nobel Prize in Physiology or Medicine "for their discovery of G-proteins and the role of these proteins in signal transduction in cells."

<span class="mw-page-title-main">Hexamethonium</span> Chemical compound

Hexamethonium is a non-depolarising ganglionic blocker, a neuronal nicotinic (nAChR) receptor antagonist that acts in autonomic ganglia by binding mostly in or on the nAChR receptor, and not the acetylcholine binding site itself. It does not have any effect on the muscarinic acetylcholine receptors (mAChR) located on target organs of the parasympathetic nervous system, nor on the nicotinic receptors at the skeletal neuromuscular junction, but acts as antagonist at the nicotinic acetylcholine receptors located in sympathetic and parasympathetic ganglia (nAChR).

The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.

<span class="mw-page-title-main">Robert Lefkowitz</span> American physician and biochemist

Robert Joseph Lefkowitz is an American physician and biochemist. He is best known for his groundbreaking discoveries that reveal the inner workings of an important family G protein-coupled receptors, for which he was awarded the 2012 Nobel Prize for Chemistry with Brian Kobilka. He is currently an Investigator with the Howard Hughes Medical Institute as well as a James B. Duke Professor of Medicine and Professor of Biochemistry and Chemistry at Duke University.

<span class="mw-page-title-main">Alpha-adrenergic agonist</span> Class of drugs

Alpha-adrenergic agonists are a class of sympathomimetic agents that selectively stimulates alpha adrenergic receptors. The alpha-adrenergic receptor has two subclasses α1 and α2. Alpha 2 receptors are associated with sympatholytic properties. Alpha-adrenergic agonists have the opposite function of alpha blockers. Alpha adrenoreceptor ligands mimic the action of epinephrine and norepinephrine signaling in the heart, smooth muscle and central nervous system, with norepinephrine being the highest affinity. The activation of α1 stimulates the membrane bound enzyme phospholipase C, and activation of α2 inhibits the enzyme adenylate cyclase. Inactivation of adenylate cyclase in turn leads to the inactivation of the secondary messenger cyclic adenosine monophosphate and induces smooth muscle and blood vessel constriction.

<span class="mw-page-title-main">Alpha-2B adrenergic receptor</span> Protein-coding gene in the species Homo sapiens

The alpha-2B adrenergic receptor, is a G-protein coupled receptor. It is a subtype of the adrenergic receptor family. The human gene encoding this receptor has the symbol ADRA2B. ADRA2B orthologs have been identified in several mammals.

<span class="mw-page-title-main">Brian Kobilka</span> American physiologist

Brian Kent Kobilka is an American physiologist and a recipient of the 2012 Nobel Prize in Chemistry with Robert Lefkowitz for discoveries that reveal the workings of G protein-coupled receptors. He is currently a professor in the department of Molecular and Cellular Physiology at Stanford University School of Medicine. He is also a co-founder of ConfometRx, a biotechnology company focusing on G protein-coupled receptors. He was named a member of the National Academy of Sciences in 2011.

<i>Journal of Pharmacology and Experimental Therapeutics</i> Academic journal

The Journal of Pharmacology and Experimental Therapeutics is a peer-reviewed scientific journal covering pharmacology. It has been published since 1909 by the American Society for Pharmacology and Experimental Therapeutics (ASPET). The journal publishes mainly original research articles, and accepts papers covering all aspects of the interactions of chemicals with biological systems.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a scientific society founded in late 1908 by John Jacob Abel of Johns Hopkins University, with the aim of promoting the growth of pharmacological research. Many society members are researchers in basic and clinical pharmacology who help develop disease-fighting medications and therapeutics. ASPET is one of the constituent societies of the Federation of American Societies for Experimental Biology (FASEB). The society's headquarters are in Rockville, MD. The current president is Michael F. Jarvis.

Martin J. Lohse is a German physician and pharmacologist.

The John J. Abel Award is an annual award presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET). The award is given for outstanding research in the field of pharmacology and/or experimental therapeutics; which comes with a $5000 prize, An engraved plaque, and all travel expenses paid to attend the ASPET Annual Meeting at Experimental Biology. The Award is named after American biochemist and pharmacologist, John Jacob Abel.

<span class="mw-page-title-main">David Siderovski</span> American pharmacologist

David Siderovski is a North American pharmacologist. Since March 2020, Siderovski has been Chair of the HSC Department of Pharmacology & Neuroscience at the University of North Texas Health Science Center. From 2012 to 2019, he was the E.J. Van Liere Medicine Professor and Chair of Physiology, Pharmacology & Neuroscience for the West Virginia University School of Medicine.

Michel Bouvier is a Canadian biochemist and molecular pharmacologist. He is a professor of biochemistry and molecular medicine at Université de Montréal; a principal investigator and the chief executive officer at the Institute for Research in Immunology and Cancer; and an associate vice-president in Research, Scientific Discovery, Creation, and Innovation at Université de Montréal. His work focuses on the study of cell signaling towards the discovery of new pharmaceutical drugs.

<span class="mw-page-title-main">Salomon Z. Langer</span>

Salomon Zender Langer is an Argentinian pharmacologist whose family had fled from Poland to Argentina in the early 1930s and were thus saved from the Holocaust during the Second World War.

Nancy Rutledge Zahniser was an American pharmacologist, best known for her work involving the mechanism of dopaminergic pathways and chemical modifications of them. Although born in Ann Arbor, Michigan, Zahniser grew up in Chillicothe, Ohio and subsequently enrolled at the College of Wooster, where she obtained a degree in chemistry. After completing her degree, Zahniser spent some time in India where she met her first husband Mark Zahniser; she later returned to the United States to attend the University of Pittsburgh School of Pharmacy, where she earned her PhD in pharmacology in 1977. Zahniser went on to complete her post-doctoral training at the University of Colorado Health Sciences Center's Department of Pharmacology and then became a part of the faculty there. In 2007, she became associate dean for research education. She played a role in advancing the careers of many post-doctoral students in her lab. In addition to her work as a professor, Zahniser was also a member of several boards, committees, review panels, and professional societies related to pharmacology, neuroscience, and addiction. She led several national research meetings from 1995-2002.

Marion Sewer (1972-2016) was a pharmacologist and professor at the University of California, San Diego's Skaggs School of Pharmacy and Pharmaceutical Sciences known for her research on steroid hormone biogenesis and her commitment to increasing diversity in science. Much of her research centered around cytochrome P450, a family of enzymes involved in the conversion of cholesterol into steroid hormones. She died unexpectedly at the age of 43 from a pulmonary embolism on January 28, 2016, while traveling through the Detroit airport.

<span class="mw-page-title-main">Namandjé Bumpus</span> American pharmacologist

Namandjé N. Bumpus is an American pharmacologist and the Chief Scientist of the Food and Drug Administration. She was previously director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, where she holds the E.K. Marshall and Thomas H. Maren professorship in pharmacology. Bumpus is known for her research on the metabolism of antiviral drugs used to treat HIV-1 and how genetic variations in drug-processing enzymes may impact these drugs' efficacy. Bumpus received a Presidential Early Career Award for Scientists and Engineers in 2016.

Joan Heller Brown is an American pharmacologist. She is Distinguished Professor and Chair of the Department of Pharmacology at UC San Diego School of Medicine. She is known for fundamental contributions to the understanding of G-protein coupled receptors (GPCRs) — molecules that span cell membranes, where they transmit messages between cells and their environments — and how GPCRs regulate cell growth and survival, in healthy and various disease states. Many therapeutic drugs work by influencing GPCRs, thus Heller Brown's discoveries have been crucial to their development.

Eva King Killam was a research pharmacologist who studied the activity of drugs on the brain and behavior, developing animal models for epilepsy and opiate dependence.

John Stephen Lazo is an American pharmacologist noted for his work discovering the fundamental mechanisms of action of small molecule therapeutics and the factors that confer drug resistance. He is a professor emeritus of pharmacology at University of Virginia.

References

  1. ↑ "Lee Limbird". Fisk University. Retrieved 12 April 2022.
  2. 1 2 3 4 Snyder, Bill (January 24, 2013). "Pharmacology society honors Limbird's impact". Vanderbilt University. Retrieved 12 April 2022.
  3. 1 2 3 "LEE E. LIMBIRD Curriculum Vitae" (PDF). Vanderbilt University. 2017. Retrieved 12 April 2022.
  4. 1 2 3 4 5 6 Limbird, Lee E. (6 January 2022). "Pushing Forward the Future Tense: Perspectives of a Scientist". Annual Review of Pharmacology and Toxicology. 62 (1): 1–18. doi: 10.1146/annurev-pharmtox-052220-123748 . ISSN   0362-1642. PMID   34339291. S2CID   236885490 . Retrieved 12 April 2022.
  5. 1 2 3 4 5 6 7 "Lee Limbird, Ph.D." Vanderbilt University. 30 July 2018. Retrieved 12 April 2022.
  6. ↑ "The 100th Commencement". College of Wooster. June 15, 1970. p. 4. Retrieved 12 April 2022.
  7. ↑ Snyderman, Ralph (3 October 2011). "Introduction of Robert J. Lefkowitz". The Journal of Clinical Investigation. 121 (10): 4192–4200. doi:10.1172/JCI60816. ISSN   0021-9738. PMC   3195491 . PMID   21965339.
  8. ↑ 2006–2010 And Beyond: Vanderbilt University Medical Center research enterprise strategic plan (PDF). Nashville, Tennessee: Vanderbilt University. 2008. p. 11.
  9. 1 2 3 "Director's Pittman Lecture To Feature Lee Limbird" (PDF). The NIH Record. September 9, 1997. pp. 1, 4. Retrieved 12 April 2022.
  10. ↑ Kohl, Kay (May 1983). "AAUW Educational Foundation letters" (PDF). NC State University Libraries. Retrieved 12 April 2022.
  11. 1 2 3 "PREVIOUS WINNERS OF SOCIETY AWARDS". American Society for Pharmacology and Experimental Therapeutics. 2009. Retrieved 12 April 2022.
  12. ↑ Cohen, Marlene L.; Brevig, Holly; Carrico, Christine; Wecker, Lynn (2007). "SPECIAL CENTENNIAL ARTICLE Women in ASPET: A Centennial Perspective" (PDF). The Pharmacologist. 49 (4): 124–137. Retrieved 2019-11-24.
  13. ↑ "Listing of Grantees". Brain & Behavior Research Foundation. Retrieved 12 April 2022.
  14. ↑ "Distinguished Alumni Award". The College of Wooster. Retrieved 12 April 2022.
  15. ↑ "Lee E. Limbird, Ph.D. Goodman & Gilman Award in Drug Receptor Pharmacology" (PDF). The Pharmacologist. 46 (1): 3–4. 2004. Retrieved 12 April 2022.
  16. ↑ "Julius Axelrod Award 2013". Catecholamine Society. Retrieved 12 April 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.